PMID- 17249256
OWN - NLM
STAT- MEDLINE
DCOM- 20071106
LR  - 20220321
IS  - 0004-5772 (Print)
IS  - 0004-5772 (Linking)
VI  - 54
DP  - 2006 Nov
TI  - Clinical decision making: managing postprandial hyperglycemia.
PG  - 871-6
AB  - The primary objective of treating all patients with diabetes is to establish and 
      maintain near-normal blood glucose levels to prevent microvascular and 
      macrovascular complications. The glycated hemoglobin (HbA(1c)) is the accepted 
      standard for monitoring overall glycemic control with treatments and management 
      strategies traditionally targeting fasting and preprandial glucose levels. 
      However, postprandial glucose levels also contribute to HbA(1c), and optimization 
      of glycemic control may also require targeting these values. Exaggerated postmeal 
      glucose excursions are common in patients with diabetes, and postprandial 
      hyperglycemia (PPHG) is an independent risk factor for cardiovascular disease. 
      Regular self-monitoring of blood glucose concentrations (SMBG) at appropriate 
      times can detect PPHG, provide patient feedback regarding meals and lifestyle, 
      and monitor response to therapy. SMBG can also help detect fluctuations in blood 
      glucose levels, which may be an additional risk factor for complications, 
      independent of HbA(1c). New therapeutic options that specifically target 
      postprandial glucose levels may improve overall glycemic control and reduce the 
      risk of microvascular and macrovascular complications.
FAU - Hurel, S J
AU  - Hurel SJ
AD  - University College London Hospital, Department of Endocrinology and Diabetes, 
      London, United Kingdom.
FAU - Mohan, V
AU  - Mohan V
LA  - eng
PT  - Journal Article
PT  - Review
PL  - India
TA  - J Assoc Physicians India
JT  - The Journal of the Association of Physicians of India
JID - 7505585
RN  - 0 (Blood Glucose)
SB  - IM
MH  - Blood Glucose/*metabolism
MH  - Blood Glucose Self-Monitoring
MH  - Cardiovascular Diseases/*prevention & control
MH  - Diabetes Mellitus/*blood
MH  - Humans
MH  - Hyperglycemia/*therapy
MH  - *Postprandial Period
MH  - Risk Factors
RF  - 44
EDAT- 2007/01/26 09:00
MHDA- 2007/11/07 09:00
CRDT- 2007/01/26 09:00
PHST- 2007/01/26 09:00 [pubmed]
PHST- 2007/11/07 09:00 [medline]
PHST- 2007/01/26 09:00 [entrez]
PST - ppublish
SO  - J Assoc Physicians India. 2006 Nov;54:871-6.